Felipe Piñol Jiménez
About
In The Last Decade
Felipe Piñol Jiménez
27 papers receiving 359 citations
Peers
Comparison fields: 5 of 70
- Oncology 191
- Surgery 90
- Pediatrics, Perinatology and Child Health 76
- Molecular Biology 69
- Epidemiology 53
Countries citing papers authored by Felipe Piñol Jiménez
This map shows the geographic impact of Felipe Piñol Jiménez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Felipe Piñol Jiménez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Felipe Piñol Jiménez more than expected).
Fields of papers citing papers by Felipe Piñol Jiménez
This network shows the impact of papers produced by Felipe Piñol Jiménez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Felipe Piñol Jiménez. The network helps show where Felipe Piñol Jiménez may publish in the future.
Co-authorship network of co-authors of Felipe Piñol Jiménez
This figure shows the co-authorship network connecting the top 25 collaborators of Felipe Piñol Jiménez. A scholar is included among the top collaborators of Felipe Piñol Jiménez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Felipe Piñol Jiménez. Felipe Piñol Jiménez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | Efficacy of Trifecting® Night Cream, a Novel Triple acting Skin Brightening Product: A Double-blind, Placebo-controlled Clinical Study. | 4 |
| 3 | 8 | |
| 4 | 25 | |
| 5 | Metaplasia intestinal en pacientes con reflujo duodenogástrico y ácidos biliares totales elevados | 1 |
| 6 | Helicobacter pylori y lesiones endoscópicas e histológicas en mucosa gástrica de pacientes de 50 años y más | 1 |
| 7 | Lesiones bucales relacionadas con las enfermedades digestivas | 2 |
| 8 | Neuropéptidos y Helicobacter pylori en la gastritis crónica | 0 |
| 9 | 64 | |
| 10 | 65 | |
| 11 | Estomatitis aftosa recurrente: Actualización | 3 |
| 12 | Características de la infección por Helicobacter pylori en pacientes con adenocarcinoma gástrico | 1 |
| 13 | RECURRENT APHTHOUS STOMATITIS: UPDATE | 12 |
| 14 | 33 | |
| 15 | Citocinas, gastritis crónica y Helicobacter Pylori | 0 |
| 16 | Ectasias vasculares del antro gástrico como causa de hemorragia digestiva crónica: Presentación de 1 caso | 0 |
| 17 | Mediadores bacterianos de la inflamación en la gastritis crónica por Helicobacter pylori | 0 |
| 18 | Pesquisaje de AgsHB y de anti-HVC en pacientes con enfermedad inflamatoria intestinal crónica | 1 |
| 19 | Gastropatía secundaria a hipertensión portal: Actualización | 0 |
| 20 | Cáncer gástrico: factores de riesgo | 6 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.